The Cooper Companies, Inc. $COO Stock Position Increased by Ruffer LLP

Ruffer LLP boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 444.2% during the third quarter, HoldingsChannel reports. The fund owned 1,347,850 shares of the medical device company’s stock after buying an additional 1,100,188 shares during the period. Cooper Companies comprises 5.1% of Ruffer LLP’s holdings, making the stock its 4th biggest position. Ruffer LLP’s holdings in Cooper Companies were worth $92,407,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Cooper Companies by 11.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 31,655 shares of the medical device company’s stock worth $2,170,000 after purchasing an additional 3,305 shares during the period. Federated Hermes Inc. purchased a new position in Cooper Companies during the third quarter worth about $58,000. Truist Financial Corp increased its position in shares of Cooper Companies by 0.6% during the third quarter. Truist Financial Corp now owns 76,747 shares of the medical device company’s stock valued at $5,262,000 after acquiring an additional 451 shares during the last quarter. MBM Wealth Consultants LLC raised its stake in shares of Cooper Companies by 21.0% in the 3rd quarter. MBM Wealth Consultants LLC now owns 20,189 shares of the medical device company’s stock valued at $1,384,000 after acquiring an additional 3,498 shares during the period. Finally, Mn Services Vermogensbeheer B.V. lifted its holdings in shares of Cooper Companies by 1.6% in the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 74,708 shares of the medical device company’s stock worth $5,122,000 after acquiring an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 0.3%

Shares of NASDAQ:COO opened at $80.48 on Thursday. The Cooper Companies, Inc. has a 52 week low of $61.78 and a 52 week high of $99.54. The company’s 50 day moving average is $80.76 and its two-hundred day moving average is $74.14. The company has a market cap of $15.77 billion, a PE ratio of 42.81, a P/E/G ratio of 2.30 and a beta of 1.03. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the firm posted $1.04 earnings per share. The company’s revenue was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Holly R. Sheffield bought 1,230 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were purchased at an average cost of $80.75 per share, with a total value of $99,322.50. Following the transaction, the insider directly owned 39,052 shares of the company’s stock, valued at approximately $3,153,449. This represents a 3.25% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares of the company’s stock, valued at $641,602.50. The trade was a 34.62% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 16,014 shares of company stock valued at $1,304,416 over the last 90 days. Insiders own 1.98% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of research reports. Piper Sandler restated an “overweight” rating and set a $94.00 price target (up from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. The Goldman Sachs Group restated a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a report on Friday, January 9th. Morgan Stanley boosted their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Monday, December 8th. Stifel Nicolaus set a $95.00 price objective on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. Finally, Citigroup reiterated a “neutral” rating and set a $88.00 target price (up from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $90.85.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.